跳至主要内容
临床试验/CTRI/2026/01/102214
CTRI/2026/01/102214尚未招募不适用

To determine the involvement of nipple areolar complex in breast cancer and to find out pre operative predictors for involvement of Nipple areolar complex in breast cancer

Dr Navdeep Kaur Lubana1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月13日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

Breast cancer is one of the most common cancers affecting women. During surgery for breast cancer, the nipple and surrounding dark area (called the nipple area) may sometimes need to be removed if it is affected by cancer. However, in many patients, this nipple area may not be involved, and preserving it can improve cosmetic appearance and body image after surgery.

The challenge for doctors is to accurately identify, before surgery, which patients have cancer involvement of the nipple area and which do not. At present, this decision is often made during or after surgery, which may lead to unnecessary removal of the nipple area in some patients.

This study aims to find out how often the nipple area is affected in patients with breast cancer and to identify factors that can help predict this involvement before surgery. These factors may include patient symptoms, findings on breast examination, imaging tests such as mammography or ultrasound, and tumour characteristics.

By identifying reliable preoperative indicators, this study may help surgeons better plan breast cancer surgery and safely preserve the nipple area in suitable patients. This could lead to improved cosmetic outcomes without compromising cancer treatment, ultimately improving patient satisfaction and quality of life.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
Female

入选标准

  • Patients must have malignant breast lesions.
  • Patients must consent to take part in the study.

排除标准

  • Patients who do not provide informed consent to participate in the study.
  • Patients with Paget’s disease of the breast.
  • Patients diagnosed with benign breast lesions.
  • Patients with recurrent breast cancer.
  • Patients who have received prior radiotherapy to the breast.
  • Patients who are medically unfit to undergo surgery.

研究者

发起方
Dr Navdeep Kaur Lubana
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Navdeep Kaur Lubana

Dr Rajendra Prasad Government

研究点 (1)

Loading locations...

相似试验